🇺🇸 FDA
Patent

US 7465794

Polynucleotides encoding recombinant respiratory syncytial viruses expressing immune modulatory molecules

granted A61KA61K2039/5254A61K39/00

Quick answer

US patent 7465794 (Polynucleotides encoding recombinant respiratory syncytial viruses expressing immune modulatory molecules) held by The United States of America, as represented by the Department of Health and Human Services expires Mon Dec 11 2028 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Department of Health and Human Services
Grant date
Tue Dec 16 2008 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 11 2028 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
63
CPC classes
A61K, A61K2039/5254, A61K39/00, A61K48/00